Inventor · disambiguated record
Takeshi Masuda
Also filed as: MASUDA TAKESHI
17 granted patents·4 pending applications·180 citations·filing 2013–2024
93Inventor score
Top patents by PatentIndex Score
21 records- 0197US10729782B2Antibody-drug conjugate produced by binding through linker having hydrophilic structureDAIICHI SANKYO CO LTD·Filed 2017·Granted Aug 4, 2020·18 cites·13 claims
- 0297US9808537B2Antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2016·Granted Nov 7, 2017·44 cites·18 claims
- 0396US10973924B2Antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2018·Granted Apr 13, 2021·9 cites·2 claims
- 0496US10195288B2Antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2013·Granted Feb 5, 2019·43 cites·35 claims
- 0595US10155821B2Anti-HER2 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2016·Granted Dec 18, 2018·17 cites·8 claims
- 0695US9872924B2Antibody-drug conjugate produced by binding through linker having hydrophilic structureDAIICHI SANKYO CO LTD·Filed 2013·Granted Jan 23, 2018·36 cites·47 claims
- 0793US11795236B2Method for treating cancer comprising administration of anti-HER2 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2018·Granted Oct 24, 2023·6 cites·12 claims
- 0893US11584800B2Method of treating cancer comprising administration of anti-HER2 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2020·Granted Feb 21, 2023·2 cites·7 claims
- 0990US12246196B2Antibody-drug conjugates comprising substituted benzo[e]pyrrolo[1,2-a][1,4]diazepinesDAIICHI SANKYO CO LTD·Filed 2022·Granted Mar 11, 2025·1 cites·34 claims
- 1089US11583590B2Antibody-pyrrolobenzodiazepine derivative conjugate and method of use thereof for treating a tumorDAIICHI SANKYO CO LTD·Filed 2021·Granted Feb 21, 2023·1 cites·30 claims
- 1189US2025049782A1Antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2024·Application pending·0 cites
- 1287US12186310B2Antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2023·Granted Jan 7, 2025·0 cites·1 claims
- 1385US11633493B2Antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2020·Granted Apr 25, 2023·1 cites·14 claims
- 1484US2025114647A1ANTIBODY-DRUG CONJUGATES COMPRISING SUBSTITUTED BENZO[e]PYRROLO[1,2-a][1,4]DIAZEPINESDAIICHI SANKYO COMPANY LIMTED·Filed 2024·Application pending·0 cites
- 1583US11628223B2Antibody-drug conjugates comprising substituted benzo[e]pyrrolo[1,2-α][1,4]diazepinesDAIICHI SANKYO CO LTD·Filed 2018·Granted Apr 18, 2023·1 cites·1 claims
- 1683US2024026030A1Method of treating cancer comprising administration of anti-her2 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2023·Application pending·0 cites
- 1778US12350344B2Methods of treating a tumor by administering a claudin-6 (CLDN6) or CLDN9 antibody-pyrrolobenzodiazepine derivative conjugateDAIICHI SANKYO CO LTD·Filed 2022·Granted Jul 8, 2025·0 cites·36 claims
- 1874US11958878B2Therapeutic agent for glycogen storage disease type IADAIICHI SANKYO CO LTD·Filed 2019·Granted Apr 16, 2024·1 cites·6 claims
- 1950US2022168440A1Antibody-pyrrolobenzodiazepine deprivative conjugateDAIICHI SANKYO CO LTD·Filed 2020·Application pending·0 cites
- 2041US12358999B2Protein recognizing drug moiety of antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2019·Granted Jul 15, 2025·0 cites·23 claims
- 2138US11185594B2(Anti-HER2 antibody)-drug conjugateDAIICHI SANKYO CO LTD·Filed 2015·Granted Nov 30, 2021·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Takeshi Masuda files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →